PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1074 participants.
Also called NCT03222128
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,074 participants
- Sponsor
- Registry
-
NCT03222128
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03222128. Allocation not applicable; no masking; primary purpose treatment. Start 2014-02-17 (actual); primary completion 2015-11-18 (actual). Results posted on 2018-08-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate
- Acronym
- PII S3i
- Condition
- Symptomatic Severe Aortic Stenosis
- Intervention (Device)
- TAVR (transcatheter aortic valve replacement)
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct03222128- Content hash
a43e5df7f616e99580e62a0c0e2bf225bec3d92ff6b5237ba8404d9512902296